Sector consensus Luye Pharma Group Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:15 17/09/2024 BST			5-day change	1st Jan Change
2.960 ^HKD	+0.34%		0.00%	-20.64%

08-30	Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4	MT
08-28	Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
LUYE PHARMA GROUP LTD.	3.275	+21.12%	3
ELI LILLY AND COMPANY	995.42	+9.85%	25
NOVO NORDISK A/S	967.54	+7.10%	26
JOHNSON & JOHNSON	171.32	+2.55%	22
ABBVIE INC.	196.30	+1.47%	27
MERCK & CO., INC.	139.03	+17.53%	26
ROCHE HOLDING AG	301.11	+13.11%	19
ASTRAZENECA PLC	183.54	+16.47%	20
NOVARTIS AG	116.54	+0.67%	20
AMGEN INC.	324.71	-2.43%	24
PFIZER, INC.	33.23	+11.41%	22
SANOFI	112.40	+9.23%	22
GILEAD SCIENCES, INC.	83.54	+0.59%	27
BRISTOL-MYERS SQUIBB COMPANY	53.34	+7.78%	21
GSK PLC	19.68	+22.27%	21
CHUGAI PHARMACEUTICAL CO., LTD	6,663.33	-2.97%	15
DAIICHI SANKYO CO., LTD.	6,512.50	+31.09%	16
HALEON PLC	3.865	-2.64%	17
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,768.83	+13.30%	18
Average	1,139.45	+9.34%	21
Weighted average by Cap.	712.46	+8.19%	23